The authors reply:.
Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Yoshiki
Y
Higashijima
Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Tetsuhiro
T
Tanaka
Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Masaomi
M
Nangaku
D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006801:Humans; D054795:Incretins / Q000378:metabolism* / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D054795:Incretins; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1